Chronic Hepatitis

High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
Rong Fan, Siru Zhao, Junqi Niu, Hong Ma, Qing Xie, Song Yang, Jianping Xie, Xiaoguang Dou, Jia Shang, Huiying Rao, Qi Xia, Yali Liu, Yongfeng Yang, Hongbo Gao, Aimin Sun, Xieer Liang, Xueru Yin, Yongfang Jiang, Yanyan Yu, Jian Sun, Nikolai V Naoumov, Jinlin Hou

Gut Oct 2024, 73 (10) 1725-1736; DOI: 10.1136/gutjnl-2024-332182
New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release
Eberhard Hildt, Jianming Hu

Gut Apr 2024, 73 (4) 566-567; DOI: 10.1136/gutjnl-2023-331462
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
Harry L A Janssen, Jinlin Hou, Tarik Asselah, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla

Gut Jul 2023, 72 (7) 1385-1398; DOI: 10.1136/gutjnl-2022-328041
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
Lena Allweiss, Barbara Testoni, Mei Yu, Julie Lucifora, Chunkyu Ko, Bingqian Qu, Marc Lütgehetmann, Haitao Guo, Stephan Urban, Simon P Fletcher, Ulrike Protzer, Massimo Levrero, Fabien Zoulim, Maura Dandri

Gut May 2023, 72 (5) 972-983; DOI: 10.1136/gutjnl-2022-328380
Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection
Elmira Aliabadi, Melanie Urbanek-Quaing, Benjamin Maasoumy, Birgit Bremer, Martin Grasshoff, Yang Li, Christian E Niehaus, Heiner Wedemeyer, Anke R M Kraft, Markus Cornberg

Gut Nov 2022, 71 (11) 2300-2312; DOI: 10.1136/gutjnl-2021-324646
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach
Mathieu Castry, Anthony Cousien, Virginie Supervie, Annie Velter, Jade Ghosn, A David Paltiel, Yazdan Yazdanpanah, Sylvie Deuffic-Burban

Gut Aug 2021, 70 (8) 1561-1569; DOI: 10.1136/gutjnl-2020-321744
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels
C Renou, P Halfon, S Pol, P Cacoub, E Jouve, J P Bronowicki, J P Arpurt, H Rifflet, M Picon, X Causse, V Canva, J Denis, A Tran, M Bourliére, D Ouzan, A Pariente, S Dantin, L Alric, V Cartier, M Reville, S Caillat-Zucman

Gut Oct 2002, 51 (4) 585-590; DOI: 10.1136/gut.51.4.585
Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases
J Miyaike, Y Iwasaki, A Takahashi, H Shimomura, H Taniguchi, N Koide, K Matsuura, T Ogura, K Tobe, T Tsuji

Gut Oct 2002, 51 (4) 591-596; DOI: 10.1136/gut.51.4.591
Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype
I Nakano, Y Fukuda, Y Katano, H Toyoda, K Hayashi, T Hayakawa, T Kumada, S Nakano

Gut Aug 2001, 49 (2) 263-267; DOI: 10.1136/gut.49.2.263
Mesalazine (5-aminosalicylic acid) induced chronic hepatitis
P Deltenre, A Berson, P Marcellin, C Degott, M Biour, D Pessayre

Gut Jun 1999, 44 (6) 886-888; DOI: 10.1136/gut.44.6.886

Main menu

Chronic Hepatitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Chronic Hepatitis

Pages